Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 161 Squamous Cell Carcinoma of Head and Neck 95 Head and Neck Neoplasms 95 Colonic Neoplasms 46 Rectal Neoplasms 39 Neoplasm Metastasis 35 Carcinoma, Non-Small-Cell Lung 29 Carcinoma, Squamous Cell 25 Pancreatic Neoplasms 18 Neoplasms 18 Esophageal Neoplasms 18 Lung Neoplasms 17 Stomach Neoplasms 13 Laryngeal Neoplasms 12 Recurrence 11 Oropharyngeal Neoplasms 11 Mouth Neoplasms 11 Esophageal Squamous Cell Carcinoma 11 Colorectal Cancer Metastatic 10 Tongue Neoplasms 9 Carcinoma 9 Breast Neoplasms 9 Nasopharyngeal Carcinoma 8 Hypopharyngeal Neoplasms 8 Adenocarcinoma Of Esophagus 8 Laryngeal Diseases 6 Salivary Gland Neoplasms 5 Neoplasms, Squamous Cell 5 Glioblastoma 5 Uterine Cervical Neoplasms 4

Interventions

Docetaxel 5 Gemcitabine 3 Vinorelbine 2 Erlotinib Hydrochloride 2 Carboplatin 2 surufatinib 1 pemigatinib 1 nimotuzumab 1 lorlatinib 1 Pemetrexed 1 Paclitaxel 1 Gene Expression Profiling 1 Cisplatin 1 Cetuximab 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Advanced Non-Small Cell Lung Cancer × Cetuximab × Clear all

NCT00330746 2012-05-18

CALC-1

National Cancer Institute, Naples

Phase 2 Completed

Advanced Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡